Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 1,580 | 9,685 | 7,572 |
| Gross Profit | N/A | N/A | 1,580 | 9,685 | 7,572 |
| Operating Expenses | 156,373 | 228,365 | 185,725 | 136,885 | 105,107 |
| Operating Income | -156,373 | -228,365 | -184,145 | -127,200 | -97,535 |
| Interest Expense | 2,559 | 3,024 | 1,267 | 791 | 0 |
| Other Income | 9,588 | 21,085 | 24,076 | 4,670 | 272 |
| Pre-tax Income | -149,344 | -210,304 | -161,336 | -123,321 | -97,263 |
| Net Income Continuous | -149,344 | -210,304 | -161,336 | -123,321 | -97,263 |
| Net Income | $-149,344 | $-210,304 | $-161,336 | $-123,321 | $-97,263 |
| EPS Basic Total Ops | -2.43 | -3.47 | -2.75 | -2.94 | -2.71 |
| EPS Basic Continuous Ops | -2.43 | -3.47 | -2.75 | -2.94 | -2.71 |
| EPS Diluted Total Ops | -2.43 | -3.47 | -2.75 | -2.94 | -2.71 |
| EPS Diluted Continuous Ops | -2.43 | -3.47 | -2.75 | -2.94 | -2.71 |
| EPS Diluted Before Non-Recurring Items | -2.40 | -3.47 | -2.75 | -2.94 | -2.71 |
| EBITDA(a) | $-150,721 | $-223,730 | $-187,294 | $-127,183 | $-94,738 |